3 results
The primary objective of this study is to quantify the reduction in lumbar pain in a GelStix* treatment group compared with a control group receiving a saline solution injection as placebo.The secondary objectives are to assess: 1. the impact of…
The anti-TIM-3 monoclonal antibody MBG453 is a novel immunotherapeutic agent with promising activity seen in AML and MDS. The purpose of the current study is to assess clinical effects of MBG453 in combination with azacitidine in adult subjects with…
The primary objective of this study is to evaluate the efficacy of psilocybin (25 mg or 10 mg) compared to 1 mg, administered under supportive conditions to adult participants with TRD, in improving depressive symptoms, as assessed by the change in…